Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2009; 54:293-302, doi:10.1016/j.jacc.2009.04.033
© 2009 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Appendix
Right arrow View Related Cardiosource Journal Scan
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hiro, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hiro, T.
Related Collections
Right arrowRelated Articles

CLINICAL RESEARCH: CLINICAL TRIALS

Effect of Intensive Statin Therapy on Regression of Coronary Atherosclerosis in Patients With Acute Coronary Syndrome

A Multicenter Randomized Trial Evaluated by Volumetric Intravascular Ultrasound Using Pitavastatin Versus Atorvastatin (JAPAN-ACS [Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome] Study)

Takafumi Hiro, MD*, Takeshi Kimura, MD{dagger}, Takeshi Morimoto, MD{ddagger}, Katsumi Miyauchi, MD§, Yoshihisa Nakagawa, MD||, Masakazu Yamagishi, MD, Yukio Ozaki, MD#, Kazuo Kimura, MD**, Satoshi Saito, MD{dagger}{dagger}, Tetsu Yamaguchi, MD{ddagger}{ddagger}, Hiroyuki Daida, MD§, Masunori Matsuzaki, MD*,* for the JAPAN-ACS Investigators

* Division of Cardiology, Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine, Ube, Japan
{dagger} Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan
{ddagger} Center for Medical Education, Kyoto University Graduate School of Medicine, Kyoto, Japan
§ Department of Cardiology, Juntendo University School of Medicine, Tokyo, Japan
|| Department of Cardiology, Tenri Hospital, Nara, Japan
Division of Cardiovascular Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Japan
# Division of Cardiology, Fujita Health University, Toyoake, Japan
** Division of Cardiology, Yokohama City University Medical Center, Yokohama, Japan
{dagger}{dagger} Department of Integrative Health Medicine, Nihon University School of Medicine, Tokyo, Japan
{ddagger}{ddagger} Toranomon Hospital, Tokyo, Japan

Manuscript received December 2, 2008; revised manuscript received March 23, 2009, accepted April 2, 2009.

* Reprint requests and correspondence: Dr. Masunori Matsuzaki, Division of Cardiology, Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi 755-8505, Japan (Email: masunori{at}yamaguchi-u.ac.jp).

Objectives: The objective of this study was to evaluate whether the regressive effects of aggressive lipid-lowering therapy with atorvastatin on coronary plaque volume (PV) in patients with acute coronary syndrome (ACS) are generalized for other statins in multicenter setting.

Background: A previous single-center study reported beneficial regressive effects of atorvastatin in patients with ACS on PV of the nonculprit site by intravascular ultrasound (IVUS) evaluation. The effect of statins other than atorvastatin on PV has not been evaluated in the setting of ACS.

Methods: The JAPAN-ACS (Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome) study was a prospective, randomized, open-label, parallel group study with blind end point evaluation conducted at 33 centers in Japan. A total of 307 patients with ACS undergoing IVUS-guided percutaneous coronary intervention were randomized, and 252 patients had evaluable IVUS examinations at baseline and 8 to 12 months' follow-up. Patients were randomly assigned to receive either 4 mg/day of pitavastatin or 20 mg/day of atorvastatin. The primary end point was the percentage change in nonculprit coronary PV.

Results: The mean percentage change in PV was –16.9 ± 13.9% and –18.1 ± 14.2% (p = 0.5) in the pitavastatin and atorvastatin groups, respectively, which was associated with negative vessel remodeling. The upper limit of 95% confidence interval of the mean difference in percentage change in PV between the 2 groups (1.11%, 95% confidence interval: –2.27 to 4.48) did not exceed the pre-defined noninferiority margin of 5%.

Conclusions: The administration of pitavastatin or atorvastatin in patients with ACS equivalently resulted in significant regression of coronary PV (Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome; NCT00242944).

Key Words: acute coronary syndrome • plaque • statins • intravascular ultrasound

Abbreviations and Acronyms
  ACS = acute coronary syndrome
  CRP = C-reactive protein
  EEM = external elastic membrane
  FAS = full analysis set
  HDL-C = high-density lipoprotein cholesterol
  IVUS = intravascular ultrasound
  LDL-C = low-density lipoprotein cholesterol
  PCI = percutaneous coronary intervention
  PV = plaque volume


Related Articles

Noninferiority of Pitavastatin in Intravascular Ultrasound Findings
Hideaki Kaneda, Ji Ma, and Toshihiro Morita
J. Am. Coll. Cardiol. 2010 55: 262-263. [Full Text] [PDF]

Inside This Issue
J. Am. Coll. Cardiol. 2009 54: A28. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Therapeutic Advances in Chronic DiseaseHome page
L. Ose
Pitavastatin: finding its place in therapy
Therapeutic Advances in Chronic Disease, March 1, 2011; 2(2): 101 - 117.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
R. P. Giugliano and E. Braunwald
The Year in Non-ST-Segment Elevation Acute Coronary Syndrome
J. Am. Coll. Cardiol., December 14, 2010; 56(25): 2126 - 2138.
[Full Text] [PDF]


Home page
Eur Heart JHome page
H. M. Garcia-Garcia, M. A. Costa, and P. W. Serruys
Imaging of coronary atherosclerosis: intravascular ultrasound
Eur. Heart J., October 2, 2010; 31(20): 2456 - 2469.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol ImgHome page
K. Inoue, S. Motoyama, M. Sarai, T. Sato, H. Harigaya, T. Hara, Y. Sanda, H. Anno, T. Kondo, N. D. Wong, et al.
Serial Coronary CT Angiography-Verified Changes in Plaque Characteristics as an End Point: Evaluation of Effect of Statin Intervention
J. Am. Coll. Cardiol. Img., July 1, 2010; 3(7): 691 - 698.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. Kaneda, J. Ma, and T. Morita
Noninferiority of Pitavastatin in Intravascular Ultrasound Findings
J. Am. Coll. Cardiol., January 19, 2010; 55(3): 262 - 263.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Hiro, T. Kimura, T. Morimoto, K. Miyauchi, Y. Nakagawa, M. Yamagishi, Y. Ozaki, K. Kimura, S. Saito, T. Yamaguchi, et al.
Reply
J. Am. Coll. Cardiol., January 19, 2010; 55(3): 263 - 263.
[Full Text] [PDF]


Home page
Oxford Textbook of Interventional CardiologyHome page
M. Mahmoudi and N. Curzen
Chapter 15 Percutaneous coronary intervention in non-ST elevation acute coronary syndrome
Oxford Textbook of Interventional Cardiology, January 1, 2010; 1(1): med-9780199569083-chapter - med-9780199569083-chapter.
[Abstract] [Full Text]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement